If you typed Salud Solutions into a search box, you are probably building a CRO shortlist. This article uses only what Salud Solutions publishes (salud-solutions.com) and compares it with bioaccess®, the First-in-Human CRO for medical devices in Latin America since 2010. It is a practitioner comparison, not a teardown.
What Salud Solutions publishes
Salud Solutions is a family-owned Buenos Aires boutique CRO dedicated to Latin America since 1999. It specializes in Phase IV, observational and real-world evidence studies, plus functional-service (FSP) support. It has local CRAs in Argentina, Peru and Brazil, with additional coverage in Chile, Ecuador, Colombia, Mexico, and Central America and the Caribbean, and it handles import licenses for investigational product, kits and equipment, with local representation when the sponsor has no entity in the country. It says eight of its last fourteen studies were Phase IV, focused on oncology and respiratory. We found no device page on its site.
Salud Solutions vs bioaccess®
| Dimension | Salud Solutions | bioaccess® |
|---|---|---|
| Core focus | LATAM late-phase / real-world evidence boutique CRO and FSP | First-in-human and early feasibility studies for medical devices |
| Geography | Local CRAs in Argentina, Peru and Brazil; coverage in Chile, Ecuador, Colombia, Mexico, Central America and the Caribbean | Latin America, since 2010 |
| Device FIH track record | No named device first-in-human study found on the public pages reviewed | Published case studies on bioaccessla.com |
| After the trial | Phase IV post-authorization studies, patient registries and real-world evidence | Live multi-country sanitary registration and in-country holder service |
Where each one fits
If you need a late-phase, observational or real-world study in South America, or extra monitoring capacity on a regional study, Salud Solutions is built for that.
If the job is a first-in-human or early feasibility study for a medical device, bioaccess® is a specialist built for exactly that, running device studies in Latin America since 2010. When the study ends, the same company can register and hold the device across the region through its market access service. Ask any CRO on your list, including Salud Solutions, for a named or de-identified device first-in-human study: device class, implant or not, number of patients, ISO 14155 monitoring plan and how the data was used in an FDA file.
Other Latin American CROs are compared in the guide to first-in-human device CROs in Latin America and on the bioaccess® compare hub.
Ready to compare a proposal? Request a first-in-human study proposal.
Competitor facts from the Salud Solutions public pages linked above and public announcements, reviewed for bioaccess® competitive research (Aug 2026–Nov 2026). Claims are theirs. No invented sponsors, prices or contacts.